DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f45bad/world_hematology_a) has announced the addition of the "World Hematology and Flow Cytometry Market Outlook: Growth Opportunities and Business Expansion Strategies" report to their offering.
“World Hematology and Flow Cytometry Market Outlook: Growth Opportunities and Business Expansion Strategies”
This report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next ten years. The report explores future marketing and technological trends in seven countries; provides market share estimates, test volume forecasts, and instrument placements; compares features of over 60 analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.
During the next ten years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
The report contains 700 pages and 250 tables.
Key Topics Covered:
I. Introduction
II. Worldwide Market and Technology Overview
III. France
IV. Germany
V. Italy
VI. Japan
VII. Spain
VIII. U.K.
IX. U.S.
X. Major Product Development Opportunities
XI. Design Criteria for Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers and Risks
XIV. Competitive Assessments
Abbott Beckman Coulter Becton Dickinson Bio-Rad DakoCytomation Horiba Iris J&J Diagnostics Nihon Kohden Roche Siemens SysmexXV. Appendix: Major Universities and Research Centers Developing Hematology/Flow Cytometry Technologies and Applications
For more information visit http://www.researchandmarkets.com/research/f45bad/world_hematology_a
No comments:
Post a Comment